Three Bangladeshi publicly traded companies - Square Pharmaceuticals, Renata and Fortune Shoes - have been listed in the Forbes ‘Asia’s Best Under a Billion 2020’ list.
The list recognises 200 top-performing small and midsized publicly traded companies in the Asia Pacific region with sales under $1 billion.
As per a Forbes statement, these companies have track records of exceptional corporate performance, with one Covid-19 caveat: the list is based on full-year data as of July 7 and does not fully reflect the impact from the pandemic-led downturn.
The companies on this list, which is unranked, were selected based on a composite score that incorporated their overall track record in measures such as debt, sales and earnings-per-share growth over both the most recent fiscal one- and three-year periods, and the strongest one- and five-year average returns on equity.
Square Pharmaceuticals, established in 1958, manufactures and markets pharmaceutical products, basic chemical and animal health products. Employing 9,234 people, it has a sales volume worth $512 million and the market capital is $1.7 billion.
On Thursday, shares of Square Pharma traded at Tk 187.10 each at the Dhaka Stock Exchange (DSE).
Renata, another pharmaceutical company, has a sales volume of $271 million, and a market capital of $1.1 billion.
With a net income of $45 million the company employs 7,324 people.
As of December 3, shares of Reneta traded at Tk 1,077 each at DSE.
Established in 2010, Fortune Shoes engages in the manufacture and exporting of footwear. As per Forbes data, the company’s market capital stood at $28 million and sales worth $18 million. The footwear maker employs 1,723 people currently.
As of December 3, shares of Fortune Shoes traded at Tk 17.30 each.